Matthew W. McClure

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Lesley Ann Calhoun, as attorney-in fact for Matthew W. McClure
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew W. McClure:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aligos Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 72,000 01 Mar 2024 Direct

Insider Reports Filed by Matthew W. McClure

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALGS Aligos Therapeutics, Inc. 01 Mar 2024 1 $0 4 Chief Medical Officer 04 Mar 2024, 17:44
ALGS Aligos Therapeutics, Inc. 27 Feb 2024 6 $0 4 Chief Medical Officer 28 Feb 2024, 17:33
ALGS Aligos Therapeutics, Inc. 08 Sep 2023 1 $0 4 Chief Medical Officer 12 Sep 2023, 16:08
ALGS Aligos Therapeutics, Inc. 15 Mar 2023 1 $0 4 Chief Medical Officer 17 Mar 2023, 16:12
ALGS Aligos Therapeutics, Inc. 07 Jul 2022 1 $0 4 Chief Medical Officer 11 Jul 2022, 16:15
ALGS Aligos Therapeutics, Inc. 27 Apr 2022 0 $0 3 Chief Medical Officer 06 May 2022, 16:12